Other
Contract With Customer Liability Revenue Recognized
Analysis
StatementCash Flow Statement
SectionOther
Metric ID:
other_contract_with_customer_liability_revenue_recognizedProduct Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Oncology | — | — | — | — | — | — | — | $100K |
| Oncology Assay Interpretation Services | $200K | $100K | $200K | $100K | $200K | $100K | $100K | — |
| Total | — | — | — | — | — | — | — | — |
Genetic Testing Services is derived from annual filings.
Genetic Testing Services, License And Related Development Services, Oncology Assay Interpretation Services, Oncology Products, Royalty were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.